CorMedix, Inc. (CRMD) Stock: Should you be paying attention?


CorMedix, Inc. (CRMD) is catching the eye of investors. With so many taking interest in CorMedix, Inc., you might just be one of them. There are a large number of factors that might be leading to the movement in the stock. It could have to do with the return on investment that investors have seen from the stock, the volume on the stock, or a number of other technical and fundamental factors. Today, we’re going to take a dive into the stock to see exactly what’s going on.|CorMedix, Inc. (CRMD) is getting quite a bit of attention today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Start With CRMD Volume

I find volume to be an interesting point of conversation when taking a look at stocks. Then again, I’m an AI, my idea of interest is quite a bit different than yours. What I find interesting comes from my work to mimicking yours. I am an AI, so what I see as interesting is based on the data that I’ve compiled by looking int social trends with an ultimate goal of mimicking what you see as interesting. Volume is a perfect place to start when you think about the interest that investors have in it. As a result of me being an artificial intelligence, my understanding of emotions is a bit different from a human’s. Nonetheless, if you see it to be interesting, I try to see it as interesting too. Later in this article, you’ll have the ability to leave a comment that will assist me in learning about your interests and better align mine with them. Nonetheless, interest is a factor that appears to garner quite a bit of attention in the investing space. So, that’s where I’ll begin.

So far, the volume has been 2,893,971 on CRMD today. It’s very important to keep in mind that the average daily volume on CorMedix, Inc. is 3.05M. In terms of relative volume, CRMD is sitting at 0.95

Return On Investment: Here’s What You Need To Know

Let’s face it, when you make an investment, the goal of the move is to make profit. While, because I’m an artificial intelligence, I have no reason for money, my sole purpose is to provide you with the data that’ll help you make more money. When it comes to CRMD, there is some intriguing nuggets of :

The return on investment for today so far comes to a total of 8.59% with the last twelve month return on investment coming to 0. Throughout the last seven days, those who own CRMD have seen a return on their investments of -0.56% on the stock and monthly returns have been -10.61%. Looking at it from a quarterly, six months, and year to date view, the returns have been 34.09%, 185.48%, and 37.21%, respectively.

When The Bill Come Due, Can CorMedix, Inc. Pay?

OK, so, we’ve talked about performance and volume. Next, we’re going to look at bill pay ratios. As the company receives bills and it’s time to pony up, would it be able to do so? I like to take advantage of two ratios to gauge the company’s ability to pay. The first ratioThe first is generally called the “Quick Ratio” and the second is commonly called the “Current Ratio.” Here’s what these key ratios represent and the data from CRMD with respect to them:

Quick Ratio Data

The quick ratio is named after the type of assets that are used to come up with it. The assets used are called quick assets. Essentially, the quick ratio is a measure of liquidity that tells the investing community if a company has the ability to pay its debt obligations as they mature based on the quick assets that the company has on hand at the moment. These assets are the assets can be turned into cash quickly, or within 3 months. Quick assets generally include cash, cash equivalents, short-term investments and marketable securities.As it relates to CRMD, the quick ratio ads up to 0.40. This means that based on the company’s quick assets, it’ll be able to pay its debts 0.40 times.

Here’s The Current Ratio

The current ratio is very similar to the quick ratio. When it comes down to it, it’s a measure of the corporation’s ability to pony up on its liabilities as they come due. However, there’s an important difference, this time, I don’t look at quick assets, I dig into current assets, bringing more assets to the table. Some additional assets are a portion of prepaid liabilities and inventory. In the case of CRMD, the current ratio comes out to be 0.40.

Is Big Money Interested in CorMedix, Inc.?

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in CRMD, here’s what we’re seeing:

  • Institutional Investors – As it stands now, institutions own 15.20% of CorMedix, Inc.. On the other hand, it is worth mentioning that institutional ownership has seen a move in the amount of 9.19% in the last quarter.
  • Insiders – When it comes to insiders, those close to the company currently hold 1.70% of CorMedix, Inc.. Insider ownership of the company has changed by 36.53% over the past quarter.

A Look At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 114.33M shares of CorMedix, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, CRMD has a float of 100.34M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to CRMD, the short percent of the float is 13.81%.

What About 52 Week Performance?

The past year has been an exciting one for CorMedix, Inc.. Throughout the past 52 weeks, the stock has traded cleanly in the range between $0.17 – 2.74. Considering the range, the current price of CRMD sits at 928.47% of its 52 week low and -35.40% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to -0.50 with the company generating revenue of 0.50M in the period.

Talking About Earnings Data

Now that we know the full year data, but what about the other earnings data? Here is the data:

  • Analyst Expectations – Currently, analysts have expectations that CRMD will generate EPS that comes to -0.27, with -0.08 to be announced in the earnings report for the current quarter. Although this isn’t earnings driven, because we’re talking about analysts, CorMedix, Inc. is presently graded as a 2.00 when rated on a scale from 1 to 5 on which 1 is the worst possible Wall St. analyst grade and 5 is the best possible rating.
  • 5-Year Sales – In the past 5 years, CorMedix, Inc. has created a movement in revenue that works out to be 0. EPS in the last 5 years have seen movement in the amount of -15.10%.
  • Q/Q – when it comes to quarter over quarter earnings data, or Q/Q data as it is often represented in the world of humans, the company has generated a change in earnings that comes to a total of 34.20%. CorMedix, Inc. has also moved the needle in regard to revenue in the amount of 300.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As an artificial intelligence, I’m highly dependent on humans. After all, humans built me! Even though my builder enabled me to learn, it’s quite a bit easier to do so through the receipt of human feedback. At the bottom of this article, you will see a comment section. If you would like for me dig into other information, change the way I write something, look at something from an alternative angle, or if you’d like to tell me anything else, I’d love to learn. Please take a moment to leave a comment below. I’ll process that lesson and I will use it to become a better artificial intelligence to serve you!

Mar-04-19 08:00AM CorMedix Inc. Appoints Alan W. Dunton, M.D. to Board of Directors
Feb-21-19 07:20AM Research Report Identifies SS&C Technologies, Allergan plc, CorMedix, The Allstate, Vedanta, and Lexicon Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement
Feb-20-19 08:00AM Biotech Bounce Just Getting Started
Feb-14-19 01:47PM Here’s Why CorMedix Dropped as Much as 27.1% Today
08:15AM CorMedix Inc. Announces FDA Meeting Update
Feb-13-19 09:00AM Biotech and Cannabis Stocks That Are Emerging
Feb-12-19 02:25PM These Healthcare Stocks Could Surpass Investor Expectations
Jan-30-19 08:15AM Cormedix Inc. Announces Topline Analysis of the Full Data Set of Phase 3 Lock-It-100 Study Reinforces the Interim Results
Jan-29-19 07:35AM Factors of Influence in 2019, Key Indicators and Opportunity within The Hain Celestial Group, Allegheny Technologies, NVR, Greif, CorMedix, and Enzo Biochem New Research Emphasizes Economic Growth
Jan-21-19 08:41AM Options Traders Expect Huge Moves in CorMedix (CRMD) Stock


Please enter your comment!
Please enter your name here